⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL2266274 | 0.95 | — | — | |
| Hydrochloric Acid SCHEMBL31504963 | 0.91 | ALDH1A1 (0.38) | — | |
| SCHEMBL8759164 | 0.84 | ALDH1A1 (0.33) | — | |
| SCHEMBL6406038 | 0.82 | ALDH1A1 (0.32) | — | |
| SCHEMBL6285161 | 0.77 | CA2 (0.35) | — | |
| SCHEMBL12299273 | 0.76 | — | — | |
| SCHEMBL24700943 | 0.70 | — | — | |
| SCHEMBL9926573 | 0.70 | — | — | |
| SCHEMBL12936971 | 0.70 | — | — | |
| SCHEMBL4404625 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 400 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250084059-A1 | CRYSTALLINE FORMS OF C21H22Cl2N4O2 | BIOMED VALLEY DISCOVERIES INC (US) | 2025-03-13 | — | — | US | claimed |
| WO-2009078036-A2 | PROCESS AND INTERMEDIATE OF LETROZOLE | SHILPA MEDICARE LTD. (IN) | 2009-06-25 | — | — | WO | claimed |
| US-20060029926-A1 | Blocking compositions for immunoassays | METRIKA, INC. (US) | 2006-02-09 | — | — | US | claimed |
| US-20260000714-A1 | C. NOVYI FOR THE TREATMENT OF SOLID TUMORS IN NON-HUMAN ANIMALS | BIOMED VALLEY DISCOVERIES INC (US) | 2026-01-01 | — | — | US | disclosed |
| EP-4653054-A2 | C. NOVYI FOR THE TREATMENT OF SOLID TUMORS IN HUMANS | Biomed Valley Discoveries, Inc. (US) | 2025-11-26 | — | — | EP | disclosed |
| US-12433920-B2 | C. novyi for the treatment of solid tumors in non-human animals | BIOMED VALLEY DISCOVERIES, INC. (US) | 2025-10-07 | — | — | US | disclosed |
| EP-4108248-B1 | C. NOVYI FOR THE TREATMENT OF SOLID TUMORS IN HUMANS | BIOMED VALLEY DISCOVERIES INC (US) | 2025-09-17 | — | — | EP | disclosed |
| CN-114835784-B | Anti-inflammatory peptides and uses thereof | 巴斯夫美容护理法国公司 | 2025-06-13 | — | — | CN | disclosed |
| CN-119678046-A | Novel Kong Shanti and holes | 牛津纳米孔科技公开有限公司 | 2025-03-21 | — | — | CN | disclosed |
| CN-119630970-A | Novel Kong Shanti and holes | 牛津纳米孔科技公开有限公司 | 2025-03-14 | — | — | CN | disclosed |
| US-20250084059-A1 | CRYSTALLINE FORMS OF C21H22Cl2N4O2 | BIOMED VALLEY DISCOVERIES INC (US) | 2025-03-13 | — | — | US | disclosed |
| WO-1983000088-A1 | CHEMOTHERAPEUTIC AGENT AND TRACER COMPOSITION AND SYSTEM FOR USE THEREOF | BIOMEDICS INC (US) | 1983-01-20 | — | — | WO | disclosed |
| US-4335043-A | Substituted N-methylene derivatives of thienamycin | MERCK & CO., INC. (US) | 1982-06-15 | — | — | US | disclosed |
| US-4329986-A | Treatment of an extracorporeal stream of blood with a dialyzable chemotherapeutic and a fluorescable tracer | BIOMEDICS, INC. (US) | 1982-05-18 | — | — | US | disclosed |
| US-4311704-A | ANTIBIOTICS | MERCK & CO., INC. (US) | 1982-01-19 | — | — | US | disclosed |
| US-4309438-A | BACTERICIDES | MERCK & CO., INC. (US) | 1982-01-05 | — | — | US | disclosed |
| US-4232030-A | ANTIBIOTICS | MERCK & CO., INC. (US) | 1980-11-04 | — | — | US | disclosed |
| US-4194047-A | Substituted N-methylene derivatives of thienamycin | MERCK & CO., INC. (US) | 1980-03-18 | — | — | US | disclosed |
| EP-0001264-A1 | Substituted N-methylene derivatives of thienamycin sulfoxide and sulfone and their preparation | MERCK & CO. INC. (US) | 1979-04-04 | — | — | EP | disclosed |
| US-4048325-A | Low toxicity method of inhibiting sickling of sickle erythrocytes | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE UNITED STATES ENERGY RESEARCH AND DEVELOPMENT ADMINISTRATION (US) | 1977-09-13 | — | — | US | disclosed |